About Akbar Khan

VP, Clinical Operations
Akbar brings 25+ years of leading clinical operations at small and large pharma/biotech companies. Excelling at clinical strategy, planning and trial management, he brings a wealth of expertise to drive Endpoint’s clinical programs forwards. With past experiences at Incyte Genomics, Quark Pharmaceuticals, Unity Biotechnology, and Radius Health, Akbar has successfully transitioned multiple programs from the preclinical stage through Phase 1, 2 and large, global Phase 3 clinical trials.